Trial Profile
A trial to study the effect of MVAX-001 for the treatment of patients with cancer.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs MVAX 001 (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2016 New trial record